Wall Street Holds Steady as Healthcare Rally Offsets Industrials Drag
Indias Gen Z Cockroach Movement Gains Momentum Amid Exam Controversy Website Taken Down
Telematics Transforming Risk Assessment in Auto Insurance Industry
Walmart Price Target Lowered by UBS to 141 After Q1 Results
Dollar Weakens Oil Prices Dip on Hopes of Hormuz Strait Agreement
GitHub Outages and Competitive Pressure Challenge Microsofts AI Coding Dominance
Atlanticus Holdings ATLCP Q1 2026 Earnings Preferred Stock Reports Strong EPS Beat Stock Rises
The RealReal REAL Q1 2026 Earnings Narrowing Losses and Positive Surprise as Consignment Model Gains Traction
CBNK Q1 2026 Earnings EPS Misses Estimates Amid Mixed Operating Environment
KFY Q1 2026 Earnings EPS Beats Estimates Stock Rises on Solid Performance
Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues
ZD Q1 2026 Earnings EPS Misses Estimates Stock Rises on Strategic Progress
Aprea Therapeutics APRE Gains 278 as Shares Approach Key Resistance at 099
CO2 Energy Transition Corp NOEM Holds Steady Near Trust Value as Support and Resistance Levels Defined
Bluerock Acquisition Corp BLRK Holds Steady at 996 Amid Quiet Trading
Pacific Biosciences Up 238 Testing Resistance Amid Sector Rotation
Rockwell Automation ROK Consolidates Near Support After Modest Gain
Nabtesco Targets EV Bus Market With AllElectric Power Steering Mass Production
Adagene Q2 2025 Earnings EPS Misses Estimates Amid Operational Progress
SES AI Corporation SES Surges 6 as Momentum Builds Near Key Resistance
Walmart Warns US Consumers May Reduce Spending Amid Rising Petrol Prices
Subramanian Swamy Calls for Ban on Cement Imports from Pakistan Citing Security Risks
Treasury Yield Surge Challenges RiskFree Status Opens Opportunities in Intermediates and Credit Markets
April Jobs Report Expected to Show Cooling but Resilient Labor Market
Tennis Stars Boycott Threat Morphs into Measured Media Protest at French Open
Veteran Trader Steve Burns Flags Overlooked Bear Market Signal Cites Three Deadly Sins for Investors
UK Startup BioOrbit Launches Drug Manufacturing to Space with SpaceX Targeting SelfInjected Cancer Therapies